PDSB Stock Analysis: Buy, Sell, or Hold?
PDSB - PDS Biotechnology Corporation Common Stock
$0.22
0.01 (4.60%)
▲
5d:
-5.25%
30d:
-68.81%
90d:
-81.16%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Get Alerted When PDSB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: PDSB shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: PDSB shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: PDSB is currently trading at $0.22, which is considered oversold relative to its 30-day fair value range of $0.34 to $0.80.
Technical Outlook: Technically, PDSB is in a strong downtrend. Immediate support is located at $0.20, while resistance sits at $0.80. The stock is showing strong short-term momentum, up 4.6% recently.
Market Sentiment: PDSB scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.75 (+2652.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PDSB is in a strong downtrend. Immediate support is located at $0.20, while resistance sits at $0.80. The stock is showing strong short-term momentum, up 4.6% recently.
Market Sentiment: PDSB scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.75 (+2652.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.34 -
$0.80
Company Quality Score
53/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: Strong upward momentum (+4.6%)
- BULLISH: Trading 2652.5% below Wall St target ($5.75)
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.34 -
$0.80
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.20
Resistance Level
$0.80
Current Trend
Strong Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.51
Wall Street Target
$5.75
(+2652.5%)
Share & Embed Analysis
Last updated: August 24, 2026 8:32 AM ET
Data refreshes hourly during market hours. Next update: 9:32 AM
Data refreshes hourly during market hours. Next update: 9:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PDSB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 33 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1173 | 43 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$49 | 39 SELL |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 26 SELL |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 49 HOLD |
